Related Experiment Video
Updated: Aug 9, 2026
07:51
Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
Implication of ENaC in salt-sensitive hypertension
1Institut de Pharmacologie et de Toxicologie, Université de Lausanne, Switzerland. ehummler@pop-server.unil.ch
Summary
The epithelial sodium channel (ENaC) is crucial for blood pressure regulation. Mouse models mimicking human diseases like PHA-1 reveal ENaC
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Arterial blood pressure relies heavily on kidney-mediated sodium balance.
- The epithelial sodium channel (ENaC) in the distal nephron regulates sodium transport, influenced by aldosterone.
- Genetic diseases Liddle's syndrome and pseudohypoaldosteronism type 1 (PHA-1) highlight ENaC's role in blood pressure homeostasis.
Purpose of the Study:
- To investigate the role of ENaC in blood pressure regulation.
- To generate and analyze mouse models for ENaC-related genetic diseases.
- To understand ENaC's function as an aldosterone effector.
Main Methods:
- Molecular analysis of human genetic diseases affecting ENaC.
- Gene-targeting and transgenic technology to create mouse models.
- Generation of alphaENaC transgenic knockout mice [alphaENaC(-/-)Tg].
Main Results:
- The alphaENaC(-/-)Tg mouse model replicated key PHA-1 features, including salt-wasting and high aldosterone levels.
- These findings confirm ENaC's critical role in sodium reabsorption and blood pressure control.
- The study provides a valuable model for investigating ENaC dysfunction.
Conclusions:
- ENaC is a key effector of aldosterone action in blood pressure regulation.
- Mouse models are essential tools for studying ENaC's role in diseases and hypertension.
- Future research can utilize these models to explore genetic and environmental factors influencing hypertension.
More Related Videos
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
10:28Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...